PCL, Inc. (KOSDAQ:241820)

South Korea · Delayed Price · Currency is KRW

6,040.00

-100.00 (-1.63%)

At close: Mar 21, 2025

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Vitro Diagnostics-Related Business	1.25B	8.43B	37.22B	46.15B	53.68B
Vitro Diagnostics-Related Business Growth	-85.22%	-77.35%	-19.35%	-14.04%	-
Total	1.25B	8.43B	37.22B	46.15B	53.68B
Total Growth	-85.22%	-77.35%	-19.35%	-14.04%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
South Korea	1.17B	2.92B	28.33B	599.06M	3.91B
South Korea Growth	-60.09%	-89.69%	4628.92%	-84.69%	-
Overseas	-	-	-	45.55B	49.77B
Overseas Growth	-	-	-	-8.48%	-
Asia	19.75M	3.87B	2.68B	-	-
Asia Growth	-99.49%	44.14%	-	-	-
Other	34.09M	137.84M	1.17B	-	-
Other Growth	-75.27%	-88.19%	-	-	-
Europe	-	1.48B	5.04B	-	-
Europe Growth	-	-70.55%	-	-	-
Total	1.22B	8.41B	37.22B	46.15B	53.68B
Total Growth	-85.49%	-77.40%	-19.35%	-14.04%	-

Source: S&P Global Market Intelligence.